Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding

The diagnosis of hereditary hemorrhagic telangiectasia (HHT) is based on the Curaçao criteria: epistaxis, telangiectases, arteriovenous malformations in internal organs, and family history. Genetically speaking, more than 90% of HHT patients show mutations in <i>ENG</i> or <i>ACVRL...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Virginia Albiñana, Angel M Cuesta, Isabel de Rojas-P, Eunate Gallardo-Vara, Lucía Recio-Poveda, Carmelo Bernabéu, Luisa María Botella
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2020-06-01
Serija:Journal of Clinical Medicine
Teme:
HHT
ALK1
endoglin
raloxifene
bazedoxifene
tranexamic acid
Online pristup:https://www.mdpi.com/2077-0383/9/6/1766
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items